Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,717 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy.
Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Scherr DS, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF. Sonpavde G, et al. Among authors: lee r. J Urol. 2011 Apr;185(4):1216-21. doi: 10.1016/j.juro.2010.11.082. Epub 2011 Feb 22. J Urol. 2011. PMID: 21334687
Tissue-based molecular markers for bladder cancer.
Barbieri CE, Lotan Y, Lee RK, Sonpavde G, Karakiewicz PI, Robinson B, Scherr DS, Shariat SF. Barbieri CE, et al. Among authors: lee rk. Minerva Urol Nefrol. 2010 Sep;62(3):241-58. Minerva Urol Nefrol. 2010. PMID: 20940694 Review.
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.
Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF. Sonpavde G, et al. Among authors: lee r. BJU Int. 2011 Sep;108(5):687-92. doi: 10.1111/j.1464-410X.2010.09902.x. Epub 2010 Nov 19. BJU Int. 2011. PMID: 21087453
Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy.
Chromecki TF, Ehdaie B, Novara G, Pummer K, Zigeuner R, Seitz C, Pycha A, Lee RK, Cha EK, Karakiewicz PI, Ng C, Raman JD, Chun FK, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Bastian PJ, Martínez-Salamanca JI, Scherr DS, Shariat SF. Chromecki TF, et al. Among authors: lee rk. World J Urol. 2011 Aug;29(4):473-80. doi: 10.1007/s00345-011-0677-0. Epub 2011 Apr 17. World J Urol. 2011. PMID: 21499902
Tissue-based molecular markers for renal cell carcinoma.
Rink M, Chun FK, Robinson B, Sun M, Karakiewicz PI, Bensalah K, Fisch M, Scherr DS, Lee RK, Margulis V, Shariat SF. Rink M, et al. Among authors: lee rk. Minerva Urol Nefrol. 2011 Dec;63(4):293-308. Minerva Urol Nefrol. 2011. PMID: 21996985 Review.
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
Rink M, Ehdaie B, Cha EK, Green DA, Karakiewicz PI, Babjuk M, Margulis V, Raman JD, Svatek RS, Fajkovic H, Lee RK, Novara G, Hansen J, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Fisch M, Scherr DS, Shariat SF; Bladder Cancer Research Consortium (BCRC); Upper Tract Urothelial Carcinoma Collaboration (UTUCC). Rink M, et al. Eur Urol. 2012 Oct;62(4):677-84. doi: 10.1016/j.eururo.2012.02.018. Epub 2012 Feb 15. Eur Urol. 2012. PMID: 22349570
11,717 results
You have reached the last available page of results. Please see the User Guide for more information.